GLAUKOS Corp
Ophthalmic med-tech and pharma company developing therapies for chronic eye diseases.
GKOS | US
Overview
Corporate Details
- ISIN(s):
- US3773221029
- LEI:
- Country:
- United States of America
- Address:
- 1 GLAUKOS WAY, 92656 ALISO VIEJO
- Website:
- https://www.glaukos.com
- Sector:
- Manufacturing
Description
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company that develops and commercializes novel therapies for chronic eye diseases. The company focuses on advancing the standard of care for conditions such as glaucoma, corneal disorders, and retinal diseases. A pioneer in the field of Micro-Invasive Glaucoma Surgery (MIGS), Glaukos is committed to innovation through significant reinvestment in research and development to create transformative treatments. In addition to its product pipeline, the company provides comprehensive clinical support and educational resources for physicians to help integrate its technologies into their practices and improve patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all GLAUKOS Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GLAUKOS Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GLAUKOS Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Spermosens_AB_publ-logo.jpg){kind=logo}